Artificial hardening for polymorphic light eruption: Practical points from ten years' experience

Photodermatology Photoimmunology and Photomedicine

Volumn 15, Issue 3-4, 1999, Pages 96-99

  Man, I ^a   Dawe, R S ^a   Ferguson, J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Desensitization; Narrowband UVB phototherapy; Polymorphic light eruption (PLE); PUVA photochemotherapy

Indexed keywords

ARTICLE; DESENSITIZATION; HUMAN; MAJOR CLINICAL STUDY; PHOTODERMATOSIS; PHOTOSTIMULATION; PRIORITY JOURNAL; SUNLIGHT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 0033063041     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1999.tb00066.x     Document Type: Article

References (20)

1. Ros AM, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatology 1986: 3: 298-302.
2. Pao C, Norris PG, Corbett M, Hawk JLM. Polymorphous light eruption: prevalence in Australia and England. Br J Dermatol 1994: 130: 62-64.
3. Hölzle E, Plewing G, Von Kries R, Lehmann P. Polymorphous light eruption. J Invest Dermatol 1987: 88: 32S-38S.
4. Frain-Bell W. The idiopathic photodermatoses. In: FrainBell W. Cutaneous Photobiology. Oxford: Oxford University Press, 1985: 24-38.
5. Jansen CT. The natural history of polymorphic light eruption. Arch Dermatol 1979: 115: 165-169.
6. Gschnait F, Hönigsmann H, Brenner W, Fritsch P. Induction of UV light tolerance by PUVA in patients with polymorphous light eruption. Br J Dermatol 1978: 99: 293-295.
7. Ortel B, Tanew A, Wolff K, Hönigsmann H. Polymorphous light eruption: action spectrum and photoprotection. J Am Acad Dermatol 1986: 14: 748-753.
8. Morison WL, Momtaz K, Mosher DB, Parrish JA. UVB phototherapy in the prophylaxis of polymorphous light eruption. Br J Dermatol 1982: 106: 231-233.
9. Van Weelden H, Van der Leun JC. Lichtinduzierte Lichttoleranz bei Photodermatosen; ein Fortschrittbericht. Z Hautkr 1983: 58: 57-59.
10. Addo HA, Sharma SC. UVB Phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. Br J Dermatol 1987: 116: 539-547.
11. Murphy GM, Logan RA, Lovell CR, Morris RW, Hawk JLM, Magnus IA. Prophylactic PUVA and UVB therapy in polymorphic light eruption - a controlled study. Br J Dermatol 1987: 116: 531-538.
12. Bilsland D, Geoge SA, Gibbs NK, Aitchison T, Johnson D, Ferguson J. A comparison of narrow band phototherapy (TL-01) and photochemotherapy (PUVA) in the management of polymorphic light eruption. Br J Dermatol 1993: 129: 708-712.
13. Bilsland D, Ferguson J. The management of polymorphic light eruption. J Dermatol Treat 1992: 3: 99-101.
14. Dawe RS, Mackie RM, Ferguson J. The Scottish Phototherapy Audit: the need for evidence based guidelines? B J Dermatol 1998: 139(suppl 51): 17 (abstract).
15. Young AR. Carcinogenicity of UVB assessed. Lancet 1995: 345: 1431-1432.
16. Parrish JA, Le Vine MJ, Morison WL, Gonzalez E, Fitzpatrick TB. Comparison of PUVA and beta-carotene in the treatment of polymorphous light eruption. Br J Dermatol 1979: 100: 187-191.
17. Horkay I, Bodolay E, Kosa A. Immunological aspects of prophylactic UVB and PUVA therapy in polymorphic light eruption. Photodermatology 1986: 3: 47-49.
18. el-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL-01) UVB irradiation: a review. J Photochem Photobiol 1997: 38: 99-106.
19. de Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR, eds. The Fundamental Bases of Phototherapy. Spa-Milano OEMF., 1996: 153-170.
20. Larkø O, Diffey B. Natural UV-B radiation received by people with outdoor, indoor, and mixed occupations and UV-B treatment of psoriasis. Clin Exp Dermatol 1983: 8: 279-285.